How is ceftobiprole used in Canada: the CLEAR study final results

George G. Zhanel; Justin Kosar; Melanie Baxter; Rita Dhami; Sergio Borgia; Neal Irfan; Gordon Dow; Maxime Dube; Teagan Rolf von den Baumen; Carlo Tascini; Anna Lee; Zain Chagla; Gabriel Girouard; Samuel Bourassa‐Blanchette; May Wu; Yoav Keynan; Andrew Walkty; James A. Karlowsky

doi:10.1080/14787210.2024.2374280

Abstract

This is the authors' abstract. We don't add key points for this paper.

We report the final results of the clinical usage of ceftobiprole in patients in Canada from data in the national CLEAR (Canadian Le adership on Antimicrobial Real-Life Usage) registry.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhanel et al. (2024) studied this question.

synapsesocial.com/papers/68e6035db6db643587596ec7 https://doi.org/10.1080/14787210.2024.2374280

View at Publisher

Ask AI

Bookmark

Abstract

This is the authors' abstract. We don't add key points for this paper.

We report the final results of the clinical usage of ceftobiprole in patients in Canada from data in the national CLEAR (Canadian Le adership on Antimicrobial Real-Life Usage) registry.

How is ceftobiprole used in Canada: the CLEAR study final results

Abstract

Ask about this paper

Discussion

Cite This Study

How is ceftobiprole used in Canada: the CLEAR study final results

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading